SEC FORM 3

Please wait

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Maloney Michael T.

(Last)

(First)

(Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS

75254

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
02/27/2026

3. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, Corporate Development

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	101,990	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
2018 February Performance Stock Options (Right to Buy)	02/28/2021	02/28/2028	Common Stock	18,876	$20.6	D
2019 February Performance Stock Options (Right to Buy)	02/24/2026	02/27/2029	Common Stock	18,682	$28.26	D
2024 February Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock⁽²⁾	3,737	⁽²⁾	D
2025 February Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock⁽²⁾	5,068	⁽²⁾	D
2026 February Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock⁽²⁾	5,013	⁽²⁾	D

Explanation of Responses:

1. Represents unvested February 2024 time-based restricted stock units that vest in full on February 28, 2027.

2. Restricted stock units are settled in shares of the Company's common stock upon vesting.

3. Represents unvested February 2025 time-based restricted stock units that vest in equal remaining increments on February 24, 2027, and February 24, 2028.

4. Represents unvested February 2026 time-based restricted stock units that vest in one-third increments on February 27, 2027, February 27, 2028, and February 27, 2029.

	Chad J. Wiener, as Attorney-in-Fact for Michael T. Maloney	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.